Literature DB >> 10928496

Atrial resection in advanced lung carcinoma under total cardiopulmonary bypass.

E R Ferguson1, M J Reardon.   

Abstract

There are few reports of a surgical approach to T4 lung carcinoma that has invaded the heart. Although most cases will be considered inoperable, cases in which there is potential for complete resection and no distant or nodal metastatic disease (T4 N0 M0, Stage IIIB) may be considered for surgical therapy. We report a case of squamous cell carcinoma of the lung with cardiac involvement, in which we performed a completion pneumonectomy using total cardiopulmonary bypass. We describe indications and techniques for use of cardiopulmonary bypass in such cases.

Entities:  

Mesh:

Year:  2000        PMID: 10928496      PMCID: PMC101043     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  4 in total

1.  Revisions in the International System for Staging Lung Cancer.

Authors:  C F Mountain
Journal:  Chest       Date:  1997-06       Impact factor: 9.410

2.  [Surgical experience of three cases of lung cancer with polypoid-type left atrial infiltration--focus on the combined resection of the left atrium using cardiopulmonary bypass].

Authors:  K Nakagawa; T Matsubara; I Kinoshita; E Tsuchiya; K Kotoda; E Hata
Journal:  Nihon Kyobu Geka Gakkai Zasshi       Date:  1985-10

3.  T4 lung tumors with infiltration of the thoracic aorta: is an operation reasonable?

Authors:  W Klepetko; W Wisser; T Bîrsan; P Mares; S Taghavi; N Kupilik; E Wolner
Journal:  Ann Thorac Surg       Date:  1999-02       Impact factor: 4.330

4.  Partial atrial resection in advanced lung carcinoma with and without cardiopulmonary bypass.

Authors:  T Shirakusa; M Kimura
Journal:  Thorax       Date:  1991-07       Impact factor: 9.139

  4 in total
  1 in total

Review 1.  Extended pneumonectomy for advanced lung cancer with cardiovascular structural invasions.

Authors:  Shi-Min Yuan
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2018-04-30       Impact factor: 0.332

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.